AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 292: H259-H269, 2007. First published September 8, 2006; doi:10.1152/ajpheart.00766.2006
0363-6135/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/1/H259    most recent
00766.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boateng, S. Y.
Right arrow Articles by Russell, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boateng, S. Y.
Right arrow Articles by Russell, B.

Cardiac dysfunction and heart failure are associated with abnormalities in the subcellular distribution and amounts of oligomeric muscle LIM protein

Samuel Y. Boateng,1 Rashad J. Belin,1 David L. Geenen,2 Kenneth B. Margulies,3 Jody L. Martin,4 Masahiko Hoshijima,5 Pieter P. de Tombe,1 and Brenda Russell1

1Department of Physiology and Biophysics, and 2Cardiology Unit, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois; 3Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania; 4Cardiovascular Institute, Loyola University Medical Center, Maywood, Illinois; and 5Center for Research in Biological Systems and Department of Medicine, University of California San Diego, La Jolla, California

Submitted 17 July 2006 ; accepted in final form 3 September 2006

Prolonged hemodynamic overload results in cardiac hypertrophy and failure with detrimental changes in myocardial gene expression and morphology. Cysteine-rich protein 3 or muscle LIM protein (MLP) is thought to be a mechanosensor in cardiac myocytes. Therefore, the subcellular location of MLP may have functional implications in health and disease. Our hypothesis is that MLP becomes mislocalized after prolonged overload, resulting in impaired mechanosensing in cardiac myocytes. Using the techniques of biochemical subcellular fractionation and immunocytochemistry, we found MLP exhibits oligomerization in the membrane and cytoskeleton of cultured cardiac rat neonatal myocytes. Nuclear MLP was always monomeric. MLP translocated to the nucleolus in response to 10% cyclic stretch at 1 Hz for 48 h. This was associated with a threefold increase in S6 ribosomal protein (P < 0.01; n = 3 cultures). Adenoviral overexpression of MLP also resulted in a twofold increase in S6 protein, suggesting that MLP can activate ribosomal protein synthesis in the nucleolus. In ventricles from aortic-banded and myocardially infarcted rat hearts, nuclear MLP increased by twofold (P < 0.01; n = 7) along with a significant decrease in the nonnuclear oligomeric fraction. The ratio of nuclear to nonnuclear MLP increased threefold in both groups (P < 0.01; n = 7). In failing human hearts, there was almost a complete loss of oligomeric MLP. Using a flag-tagged adenoviral MLP, we demonstrate that the COOH terminus is required for oligomerization and that this is a precursor to stretch sensing and subsequent nuclear translocation. Therefore, reduced oligomeric MLP in the costamere and cytoskeleton may contribute to impaired mechanosensing in heart failure.

hypertrophy; mechanosensing; cytoskeleton; nucleocytoplasmic shuttling



Address for reprint requests and other correspondence: B. Russell, Dept. of Physiology and Biophysics (M/C 901), Univ. of Illinois at Chicago, 835 S. Wolcott Ave., Chicago IL 60612-7342 (e-mail: russell{at}uic.edu)




This article has been cited by other articles:


Home page
Circ. Res.Home page
A. M. Samarel
PICOT: A Multidomain Scaffolding Inhibitor of Hypertrophic Signal Transduction
Circ. Res., March 28, 2008; 102(6): 625 - 627.
[Full Text] [PDF]


Home page
Circ. Res.Home page
D. Jeong, J. M. Kim, H. Cha, J. G. Oh, J. Park, S.-H. Yun, E.-S. Ju, E.-S. Jeon, R. J. Hajjar, and W. J. Park
PICOT Attenuates Cardiac Hypertrophy by Disrupting Calcineurin-NFAT Signaling
Circ. Res., March 28, 2008; 102(6): 711 - 719.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.